No association between use of phosphodiesterase 5 inhibitors and colorectal cancer in men with erectile dysfunction.
Lucía Cea-SorianoLuis Alberto García-RodríguezPublished in: Pharmacoepidemiology and drug safety (2020)
Our results do not support an increased risk of CRC associated with the use of PDE5 inhibitors among men with erectile dysfunction.
Keyphrases